Comparison of Fixed‐Dose Clopidogrel/Asetylsalicylic Acid Combination and Standard Loading Strategy During Percutaneous Coronary Intervention in Chronic Coronary Syndrome
Catheterization and Cardiovascular Interventions · 2025
DOI: 10.1002/ccd.70136 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Catheterization and Cardiovascular Interventions, 2025. Verfasst von Ahmet Anıl Başkurt und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Bakırçay University, Izmir, Turkey. Hauptthemen laut MEDLINE: Percutaneous Coronary Intervention, Clopidogrel, Platelet Aggregation Inhibitors, Aspirin. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Background
Dual antiplatelet therapy (DAPT), comprising acetylsalicylic acid and a P2Y12 receptor inhibitor such as clopidogrel, is the cornerstone of management in patients undergoing percutaneous coronary intervention (PCI). While conventional loading doses of acetylsalicylic acid and clopidogrel are well established, there is limited evidence supporting the use of fixed‐dose combinations (FDCs) for loading therapy in patients with chronic coronary syndrome (CCS).
Aims
This study aims to evaluate the efficacy and safety of an FDC of clopidogrel and acetylsalicylic acid (75/75 mg, four tablets) compared to the standard loading regimen in patients with CCS undergoing elective PCI.
Methods
In this prospective observational study, patients were divided into two groups based on the antiplatelet loading strategy: conventional loading (acetylsalicylic acid 300 mg and clopidogrel 300–600 mg) and FDC group (four tablets of 75/75 mg). Baseline demographic, clinical, laboratory, and procedural characteristics were compared. The primary outcomes were 1‐month rates of major adverse cardiovascular events (MACE), stent thrombosis, bleeding (BARC criteria), and mortality.
Results
A total of 410 patients were included (conventional: 326; FDC: 84). There were no statistically significant differences in baseline demographic or procedural characteristics between the groups. Laboratory findings and 1‐month clinical outcomes, including MACE, bleeding, and mortality, were similar ( p > 0.05 for all outcomes).
Conclusion
Fixed‐dose clopidogrel/acetylsalicylic acid combination may be a feasible and clinically comparable option in carefully selected CCS patients to standard loading in CCS patients undergoing elective PCI. Its use may simplify treatment regimens.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiology, Bakırçay University, Izmir, Turkey.
ORCID-Profile: Ahmet Anıl Başkurt, Yusuf Demir, Ferhat Siyamend Yurdam
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Başkurt, A. A., Şenöz, O., Demir, Y., Bakır, E. O., Yurdam, F. S., Gürses, E., Koyuncu, İ., Erseçgin, A., Aydın, S., Emren, Z. Y., & Gül, İ. (2025). Comparison of Fixed‐Dose Clopidogrel/Asetylsalicylic Acid Combination and Standard Loading Strategy During Percutaneous Coronary Intervention in Chronic Coronary Syndrome. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70136
Vancouver
Başkurt AA, Şenöz O, Demir Y, Bakır EO, Yurdam FS, Gürses E, et al. Comparison of Fixed‐Dose Clopidogrel/Asetylsalicylic Acid Combination and Standard Loading Strategy During Percutaneous Coronary Intervention in Chronic Coronary Syndrome. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70136
BibTeX
@article{Bakurt2025,
author = {Başkurt, Ahmet Anıl and Şenöz, Oktay and Demir, Yusuf and Bakır, Eren Ozan and Yurdam, Ferhat Siyamend and Gürses, Ecem and Koyuncu, İlhan and Erseçgin, Ahmet and Aydın, Saadet and Emren, Zeynep Yapan and Gül, İlker},
title = {Comparison of Fixed‐Dose Clopidogrel/Asetylsalicylic Acid Combination and Standard Loading Strategy During Percutaneous Coronary Intervention in Chronic Coronary Syndrome},
journal = {Catheterization and Cardiovascular Interventions},
year = {2025},
doi = {10.1002/ccd.70136}
}
EUVIMED